Tert-butyl 4-tert-butyl-1,4-diazepane-1-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂卓
• 英文名称: Tert-butyl 4-tert-butyl-1,4-diazepane-1-carboxylate
• 英文别名: tert-butyl 4-tert-butyl-1,4-diazepane-1-carboxylate
• 化学式: C₁₄H₂₈N₂O₂
• 分子量: 256.38
• InChiKey: QSKCPTZQWNJHJE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  32.8
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• [EN] MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR<br/>[FR] MODULATEURS DU RÉGULATEUR DE LA CONDUCTANCE TRANSMEMBRANAIRE DE LA MUCOVISCIDOSE
  申请人：VERTEX PHARMA

  公开号：WO2022076625A1

  公开（公告）日：2022-04-14

  This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) having core structure (I), pharmaceutical compositions containing at least one such modulator, methods of treatment of CFTR mediated diseases, including cystic fibrosis, using such modulators and pharmaceutical compositions, combination pharmaceutical compositions and combination therapies, and processes and intermediates for making such modulators.

  本发明提供了囊性纤维化跨膜传导调节因子（CFTR）的调节剂，其具有核心结构（I），包含至少一种这样的调节剂的制药组合物，使用这样的调节剂和制药组合物治疗CFTR介导的疾病，包括囊性纤维化，组合制药组合物和组合疗法，以及制造这样的调节剂的过程和中间体。
• Tricyclic heterocycles as BET protein inhibitors
  申请人：Incyte Corporation

  公开号：US10464947B2

  公开（公告）日：2019-11-05

  The present invention relates to tricyclic heterocycles of Formula (I): which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.

  本发明涉及式 (I) 的三环杂环： 它们是 BET 蛋白如 BRD2、BRD3、BRD4 和 BRD-t 的抑制剂，可用于治疗癌症等疾病。
• 1,3-DIARYL-SUBSTITUTED HETEROCYCLIC PESTICIDES
  申请人：E I DU PONT DE NEMOURS AND COMPANY

  公开号：US20140249025A1

  公开（公告）日：2014-09-04

  Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein Q is and Z 1 , Z 2 , J 1 , J 2 , M, R 1a , R 1b , R 2a , R 2b , R 2c , R 2d and R 14 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
• US20140275030A1
  申请人：——

  公开号：US20140275030A1

  公开（公告）日：2014-09-18
• TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS
  申请人：Incyte Corporation

  公开号：US20170210754A1

  公开（公告）日：2017-07-27

  The present invention relates to tricyclic heterocycles which are inhibitors of BET proteins such as BRD2, BRD3, BRD4, and BRD-t and are useful in the treatment of diseases such as cancer.